GB1584089A - Antihypertensive pharmaceutical compositions - Google Patents

Antihypertensive pharmaceutical compositions Download PDF

Info

Publication number
GB1584089A
GB1584089A GB35524/77A GB3552477A GB1584089A GB 1584089 A GB1584089 A GB 1584089A GB 35524/77 A GB35524/77 A GB 35524/77A GB 3552477 A GB3552477 A GB 3552477A GB 1584089 A GB1584089 A GB 1584089A
Authority
GB
United Kingdom
Prior art keywords
compositions
weight
triamterene
hydrochlorothiazide
receptor blocking
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB35524/77A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roehm Pharma GmbH
AstraZeneca SAS
Original Assignee
Roehm Pharma GmbH
ICI Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roehm Pharma GmbH, ICI Pharma SA filed Critical Roehm Pharma GmbH
Publication of GB1584089A publication Critical patent/GB1584089A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB35524/77A 1976-08-27 1977-08-24 Antihypertensive pharmaceutical compositions Expired GB1584089A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762638716 DE2638716A1 (de) 1976-08-27 1976-08-27 Antihypertensiva

Publications (1)

Publication Number Publication Date
GB1584089A true GB1584089A (en) 1981-02-04

Family

ID=5986558

Family Applications (1)

Application Number Title Priority Date Filing Date
GB35524/77A Expired GB1584089A (en) 1976-08-27 1977-08-24 Antihypertensive pharmaceutical compositions

Country Status (4)

Country Link
JP (1) JPS5350340A (cg-RX-API-DMAC10.html)
DE (1) DE2638716A1 (cg-RX-API-DMAC10.html)
FR (1) FR2362636A1 (cg-RX-API-DMAC10.html)
GB (1) GB1584089A (cg-RX-API-DMAC10.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0154009A1 (en) * 1983-12-09 1985-09-11 Euro-Celtique S.A. Use of a thiazide diuretic for the manufacture of a non-diuretic antihypertensive medicament
GB2173399A (en) * 1985-02-05 1986-10-15 Sandoz Ltd Compositions containing 3-aminopropoxy-indoles for treating hypertension

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0022330B1 (en) * 1979-07-10 1983-12-21 Smithkline Beckman Corporation Synergistic antihypertensive compositions
DE3016818A1 (de) * 1980-05-02 1982-02-04 Röhm Pharma GmbH, 6100 Darmstadt Diagnostisches verfahren zur bestimmung der leberfunktion
DE3025367A1 (de) * 1980-07-04 1982-01-28 Hoechst Ag, 6000 Frankfurt Salz aus furosemid oder piretanid als saeurekomponente und penbutolol oder (-)-3-(4- (3-(3,4-dimethoxyphenylaethylamino)-2-hydroxy-propoxy) -phenyl ) -crotonsaeurenitril als basenkomponente, verfahren zu seiner herstellung, dieses enthaltendes mittel und dessen verwendung
EP0081006B1 (en) * 1981-12-08 1985-09-25 Smithkline Beckman Corporation Pharmaceutical compositions comprising 7,8-dihydroxy-1(hydroxyphenyl)-2,3,4,5-tetrahydro-1h-3-benzazepine derivatives and a beta-adrenergic blocking compound

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT336176B (de) 1971-12-10 1977-04-25 Sandoz Ag Verfahren zur herstellung eines pharmazeutischen praparates

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU602899B2 (en) * 1983-12-07 1990-11-01 Euro-Celtique S.A. Treatment of hypertension, compounds and compositions for antihypertension and diuresis
EP0154009A1 (en) * 1983-12-09 1985-09-11 Euro-Celtique S.A. Use of a thiazide diuretic for the manufacture of a non-diuretic antihypertensive medicament
GB2173399A (en) * 1985-02-05 1986-10-15 Sandoz Ltd Compositions containing 3-aminopropoxy-indoles for treating hypertension
AT393960B (de) * 1985-02-05 1992-01-10 Sandoz Ag Verfahren zur kombination eines beta-adrenorezeptorblockers und eines diuretikums

Also Published As

Publication number Publication date
DE2638716A1 (de) 1978-03-02
FR2362636B1 (cg-RX-API-DMAC10.html) 1980-12-05
JPS5350340A (en) 1978-05-08
FR2362636A1 (fr) 1978-03-24

Similar Documents

Publication Publication Date Title
EP1437131B1 (en) Use of ramipril for the prevention of diabetes in a patient with no preexisting congestive heart failure
US4742054A (en) Treatment of mammals suffering from damage to the central nervous system
Plänitz Comparison of moxonidine and clonidine HCl in treating patients with hypertension
US6818647B2 (en) Method and composition for restoring diuretic and renal function
GB1584089A (en) Antihypertensive pharmaceutical compositions
AU666992B2 (en) Pharmaceutical composition for preventing or treating arteriosclerosis
US20050038017A1 (en) Method and composition for restoring diuretic and renal function
IE48306B1 (en) Medicaments for treating hypertension
CA2295101C (en) Adenosine a1 receptor antagonist containing composition and method for restoring diuretic and renal function
AU768880B2 (en) Use of vasopeptidase inhibitors to treat angina pectoris
US4298611A (en) Process for reducing blood pressure in animals
US4855325A (en) Treatment of mammals suffering from damage to the central nervous system
US4310549A (en) Treatment of hypertension with 1-tert.-butylamino-3-(2,5-dichlorophenoxy)-2-propanol
US4215130A (en) Antihypertensive compositions of N-(2,6-dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine and N-(2-chloroethyl)-N-(1-methyl-2-phenoxyethyl)-benzenemethanamine
EP0256629A2 (en) Tolrestat or a salt thereof as an immuno-stimulating agent
DE2660861C2 (cg-RX-API-DMAC10.html)
KR0132568B1 (ko) 이뇨 또는 항고혈압 조성물
EP0759298B1 (en) Use of 4-amino-6-hydroxypyrazolo[3,4-d]pyrimidine for the manufacture of an antihypertensive agent
US4156003A (en) Treatment of hypertension with combination of clofibrinic acid or clofibrate with cinnarizine
US4983582A (en) Preventive and therapeutic method for hypertension
CA1336959C (en) Uricosuric composition
US4585794A (en) Method for treating renal insufficiency
GB2173399A (en) Compositions containing 3-aminopropoxy-indoles for treating hypertension
IE43955B1 (en) Pharmaceutical composition and dosage units thereof
AU607908B2 (en) Pharmaceutical compositions for use in improving oxygenation of the brain and a process for their production

Legal Events

Date Code Title Description
PS Patent sealed
PE20 Patent expired after termination of 20 years

Effective date: 19970823